Dark

CELG
Celgene Corp.
stock NASDAQ

Inactive

Nov 20, 2019

108.24USD+0.102%(+0.11)191,230,586

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Headquarters

NJ, USA

Industry

Biotechnology

Last Split

Feb 27, 20062for1

AMGN ALXN GILD ILMN BIIB JNJ LLY EPZM OMED XLRN XLV

Profile

Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.

document.getElementById("DW3WBg").onerror = function(){this.style.display='none';}; .dark-mode .cQNZ6P{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .cQNZ6P{ color: #333333; background-color: white; border: 2px solid #333333; }CELGCelgene Corp.stock NASDAQ

CELG
Celgene Corp.
stock NASDAQ